Tramadol in Workers Compensation Claims

Managing tramadol prescribing in workers compensation claims. Understand the risks, red flags, and when to refer for medication review.

Published: 3 April 2026 | Updated: 3 April 2026

What is Tramadol?

Tramadol is a synthetic opioid painkiller used for moderate pain relief. It's available in immediate-release tablets (typically 50 mg, taken every 4-6 hours) and extended-release formulations (100-300 mg daily). Unlike pure opioids like morphine or oxycodone, tramadol also has noradrenaline and serotonin reuptake inhibition properties, meaning it works through multiple pain pathways, not just opioid receptors.

In workers compensation claims, tramadol is commonly prescribed for musculoskeletal injuries, back pain, and post-injury pain management. It's often seen as a "middle ground" between paracetamol and stronger opioids, which appeals to prescribers cautious about high-dose morphine or oxycodone. However, this perception obscures significant safety concerns that you should understand as a claim handler.

The Safety Concerns

Seizure Risk

Tramadol increases seizure risk at higher doses. This risk rises substantially above 400 mg daily and is higher in patients with pre-existing seizure disorders, head injury, or those on medications that lower seizure threshold. In workers compensation claims involving head injury or neurological injury, tramadol use is particularly concerning. A claimant on tramadol who experiences a seizure may attribute it to the original injury when tramadol itself is the culprit. If your claimant has seizures and is on tramadol, this should trigger immediate review.

Serotonin Syndrome

Tramadol inhibits serotonin reuptake. When combined with other serotonergic medications (SSRIs like sertraline, SNRIs like venlafaxine, or MAO inhibitors), it can cause serotonin syndrome: agitation, confusion, muscle rigidity, hyperthermia, and potentially life-threatening complications. Many claimants are on antidepressants for injury-related depression or anxiety. If your claimant is on both tramadol and an SSRI or SNRI without clear documentation that this combination has been assessed for safety, this is a red flag.

Respiratory Depression and Overdose

Although tramadol has a lower respiratory depression risk than morphine at equivalent analgesic doses, it remains an opioid and carries overdose risk, particularly at high doses or when combined with other CNS depressants. Claimants on tramadol plus benzodiazepines or alcohol are at elevated overdose risk.

Red Flags in Tramadol Claims

• Tramadol combined with SSRIs, SNRIs, or other serotonergic medications without documented safety review.
• Tramadol prescribed to a claimant with a history of seizures or head injury, or in doses above 400 mg daily.
• Claimant reports dizziness, sedation, confusion, or muscle stiffness developing after tramadol initiation; these may signal serotonin syndrome or other toxicity.
• Concurrent tramadol and benzodiazepine use, particularly at high doses.
• Tramadol prescribed indefinitely post-injury without periodic reassessment or documented pain management plan.
• Prescriber unfamiliar with tramadol's specific adverse effects or drug interactions.
• Claimant on multiple opioids including tramadol (polypharmacy that increases seizure and overdose risk).
• No documented baseline pain assessment or follow-up to check whether tramadol is achieving pain relief.

When Should You Refer for Pharmacy Review?

Tramadol Doses in Claims

Typical immediate-release tramadol dosing is 50 mg every 4-6 hours, up to a maximum of 400 mg daily. Extended-release forms usually range from 100-300 mg daily. In your claims, watch for doses consistently above 400 mg daily, as this threshold increases seizure risk substantially. Also watch for rapid escalation: if a claimant started on 100 mg daily and is now on 300 mg daily within a few months, this suggests inadequate pain control or concerning prescribing patterns.

Questions to Ask Your Pharmacist

1. Is tramadol still clinically justified given the time since injury and documented pain levels?
2. Are there any serotonergic medications in the claimant's regimen that could interact with tramadol?
3. Does the claimant have any condition (seizure history, head injury, neurological disease) that would make tramadol risky?
4. Is the current dose within safe limits, or does it exceed 400 mg daily?
5. Are there documented adverse effects (seizures, dizziness, confusion, muscle symptoms) that should trigger dose reduction or cessation?
6. What alternative pain management strategies are in place?
7. Is there a documented tapering plan if tramadol continues long-term?
8. Could the claimant transition to a safer, non-opioid alternative?

Transitions from Tramadol

If your claimant is on tramadol long-term with concerns identified (serotonin interaction, seizure risk, inadequate pain relief), your pharmacist should recommend transition. Options include gradual tapering combined with non-opioid pain management (paracetamol, NSAIDs if appropriate, nerve pain agents, topical analgesics), physiotherapy, and psychological support. Unlike pure opioids, tramadol tapering can sometimes be done relatively quickly without severe withdrawal, though gradual reduction is still preferred.

Why Claim Handlers Should Care

Tramadol is cheaper than many opioids and is widely prescribed in general practice, creating a false sense of safety. However, it carries distinct risks that generic opioid assessment misses. Many claims that appear reasonable (moderate painkiller for injury pain) mask safety concerns that specialist pharmacy review would identify. Systematic review of tramadol use, particularly in claimants on multiple medications, often leads to safer prescribing and better claimant outcomes.

Summary: Your Decision Framework

Tramadol is appropriate for acute post-injury pain in workers compensation claims. However, long-term tramadol use, particularly at high doses, or in combination with other serotonergic or CNS depressant medications, requires specialist assessment. If your claimant is on tramadol beyond the acute phase, or if there are any concerns about drug combinations, seizure history, or documented adverse effects, refer for a medication review. Your pharmacist can identify safety concerns and recommend safer alternatives.